<DOC>
	<DOCNO>NCT01156142</DOCNO>
	<brief_summary>RATIONALE : Doxepin hydrochloride may effective treatment oral mucositis pain patient undergoing radiation therapy without chemotherapy . PURPOSE : This randomized phase III trial study doxepin hydrochloride see well work compare placebo treat oral mucositis pain patient head neck cancer undergo radiation therapy without chemotherapy .</brief_summary>
	<brief_title>Doxepin Hydrochloride Treating Oral Mucositis Pain Patients With Head Neck Cancer Undergoing Radiation Therapy With Without Chemotherapy</brief_title>
	<detailed_description>OUTLINE : This multicenter study . Patients stratify accord gender , concurrent radiosensitizing chemotherapy ( yes v ) , age ( &lt; 60 year vs ≥ 60 year ) . Patients randomize 1 2 treatment arm . - Arm I : Patients receive doxepin hydrochloride oral rinse ( swish , gargle , spit ) * 1 minute day 1 . Patients may crossover arm II day 2 . - Arm II : Patients receive placebo oral rinse ( swish , gargle , spit ) * 1 minute day 1 . Patients may crossover arm I day 2 . The primary secondary objective detail . Primary Objective : Determine whether doxepin oral rinse effective reduce OM-related pain patient undergo RT oral cavity , measure patient-reported questionnaire 5,15 , 30 , 60 , 120 240 minute Secondary Objectives : 1 . Assess adverse event profile doxepin rinse use patient-reported questionnaire 5 , 15 , 30 , 60 , 120 240 minute domain unpleasant taste , burn sting discomfort , drowsiness . 2 . Compare incidence use alternative analgesic 4 hour , doxepin oral rinse placebo arm . 3 . Assess patient preference continue therapy oral rinse initial test rinse cross-over phase . NOTE : * Patients instruct avoid take medication mucositis pain 60 minute study medication . After complete study therapy , patient option receive doxepin hydrochloride oral rinse every 4 hour need radiotherapy . Patients complete questionnaire baseline , 5 , 15 , 30 , 60 , 120 , 240 minute study medication . Patients choose continue doxepin hydrochloride oral rinse also complete weekly questionnaire .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<mesh_term>Doxepin</mesh_term>
	<criteria>1 . ≥ 18 year age 2 . Histologic proof malignancy currently undergo course RT ( without chemotherapy ) dose ≥ 5000 cGy use 1.60 2.20 Gy per fraction . Note : At least one third oral cavity mucosa must include radiation therapy field . 3 . ≥ 4 oral pain felt related mucositis patient want relief measure Numeric Measure Oral Pain . Note : An oral exam confirm presence mucositis perform enrol clinician addition patient feedback . 4 . Ability complete questionnaire ( ) independently assistance 5 . ECOG Performance Status 0 , 1 2 . 6 . Provide informed write consent . 7 . Willingness return enrol institution followup . 1 . Known allergy doxepin , tricyclic antidepressant , know component drug formulation 2 . Use tricyclic antidepressant monoamine oxidase inhibitor within 2 week prior registration 3 . Current untreated unresolved oral candidiasis oral HSV infection 4 . Current untreated narrow angle glaucoma 5 . Current untreated urinary retention ≤ 6 week prior registration 6 . Comorbid systemic illness severe concurrent disease , judgment investigator , would make patient inappropriate entry study interfere significantly proper assessment safety toxicity prescribe regimens 7 . Any following study involve study agent whose genotoxic , mutagenic teratogenic effect develop fetus newborn unknown : Pregnant woman Nursing woman Men woman childbearing potential unwilling employ adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>oral complication radiation therapy</keyword>
	<keyword>mucositis</keyword>
	<keyword>pain</keyword>
	<keyword>stage I squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent verrucous carcinoma larynx</keyword>
	<keyword>squamous cell carcinoma larynx</keyword>
	<keyword>verrucous carcinoma larynx</keyword>
	<keyword>recurrent adenoid cystic carcinoma oral cavity</keyword>
	<keyword>recurrent mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>recurrent verrucous carcinoma oral cavity</keyword>
	<keyword>adenoid cystic carcinoma oral cavity</keyword>
	<keyword>mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>verrucous carcinoma oral cavity</keyword>
	<keyword>squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent basal cell carcinoma lip</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>basal cell carcinoma lip</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent lymphoepithelioma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>lymphoepithelioma nasopharynx</keyword>
	<keyword>squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent lymphoepithelioma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>lymphoepithelioma oropharynx</keyword>
	<keyword>squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>high-grade salivary gland mucoepidermoid carcinoma</keyword>
	<keyword>low-grade salivary gland mucoepidermoid carcinoma</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>salivary gland acinic cell tumor</keyword>
	<keyword>salivary gland adenocarcinoma</keyword>
	<keyword>salivary gland adenoid cystic carcinoma</keyword>
	<keyword>salivary gland anaplastic carcinoma</keyword>
	<keyword>salivary gland malignant mixed cell type tumor</keyword>
	<keyword>salivary gland poorly differentiate carcinoma</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>salivary gland cancer</keyword>
	<keyword>tongue cancer</keyword>
</DOC>